Szentmiklosi, A.J., Galajda, Z., Cseppento, á., et al. (2015) The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions. Current Pharmaceutical Design, 21, 965-976.
https://doi.org/10.2174/1381612820666141029100346

has been cited by the following article:

• TITLE: Atrial Fibrillation Induction in a Pediatric Patient during Adenosine Administration

  AUTHORS: Jeffrey A. Robinson, Christopher S. Snyder

  KEYWORDS: Pediatric, Adolescent, Electrophysiology, Atrial Fibrillation, Adenosine

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.7 No.3, March 8, 2017

  ABSTRACT: Adenosine by rapid intravenous bolus is frequently utilized in clinical practice as both a pharmacologic treatment for supraventricular (reentrant) tachycardia and in provocative testing for the diagnosis of Wolff-Parkinson-White (WPW) syndrome. This is a case report of an otherwise healthy adolescent female who received adenosine during a provocative test for WPW syndrome. Immediately after receiving adenosine, the patient had a self-limited episode of atrial fibrillation. When administering adenosine, teams should be aware of the potential adverse effects and be prepared to treat appropriately.